NCT02539264View on ClinicalTrials.gov

Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)

CompletedOBSERVATIONAL
Enrollment

920

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions
Obstructive Sleep ApneaObesitySmoking
Interventions
OTHER

Smoking

Influence of smoking on parameters derived from overnight PSG

OTHER

Obesity

Influence of obesity on parameters derived from overnight PSG

OTHER

Benzodiazepine use

Influence of benzodiazepine use on parameters derived from overnight PSG

Sponsors

Lead Sponsor

Astes
All Listed Sponsors
lead

Astes

OTHER

NCT02539264 - Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA) | Biotech Hunter | Biotech Hunter